Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

IART

Integra LifeSciences (IART)

Integra LifeSciences Holdings Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IART
DateTimeSourceHeadlineSymbolCompany
2:07PMiHub NewswireFeaturedNanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon
04/30/20244:20PMGlobeNewswire Inc.Integra LifeSciences to Spotlight CereLink® Intracranial Pressure (ICP) Monitoring System at the American Association of Neurological Surgeons (AANS) Annual Scientific MeetingNASDAQ:IARTIntegra LifeSciences Holdings Corporation
04/18/20245:24PMGlobeNewswire Inc.Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024NASDAQ:IARTIntegra LifeSciences Holdings Corporation
04/01/20244:15PMGlobeNewswire Inc.Integra LifeSciences Completes the Acquisition of Acclarent, Inc.NASDAQ:IARTIntegra LifeSciences Holdings Corporation
03/11/20248:30AMGlobeNewswire Inc.Integra LifeSciences Launches MicroMatrix® Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex CasesNASDAQ:IARTIntegra LifeSciences Holdings Corporation
03/08/20244:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IARTIntegra LifeSciences Holdings Corporation
03/06/20245:53PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IARTIntegra LifeSciences Holdings Corporation
02/28/20246:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IARTIntegra LifeSciences Holdings Corporation
02/28/20246:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IARTIntegra LifeSciences Holdings Corporation
02/28/20246:00AMGlobeNewswire Inc.Integra LifeSciences Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial GuidanceNASDAQ:IARTIntegra LifeSciences Holdings Corporation
02/28/20246:00AMGlobeNewswire Inc.Integra LifeSciences Announces Leadership Transition PlanNASDAQ:IARTIntegra LifeSciences Holdings Corporation
02/27/20245:15PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:IARTIntegra LifeSciences Holdings Corporation
02/22/20244:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IARTIntegra LifeSciences Holdings Corporation
02/22/20244:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IARTIntegra LifeSciences Holdings Corporation
02/22/20244:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IARTIntegra LifeSciences Holdings Corporation
02/22/20244:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IARTIntegra LifeSciences Holdings Corporation
02/13/20243:30PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IARTIntegra LifeSciences Holdings Corporation
02/09/20245:49PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:IARTIntegra LifeSciences Holdings Corporation
02/07/20249:15AMGlobeNewswire Inc.Integra LifeSciences to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024NASDAQ:IARTIntegra LifeSciences Holdings Corporation
01/25/20241:48PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IARTIntegra LifeSciences Holdings Corporation
01/19/20244:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IARTIntegra LifeSciences Holdings Corporation
01/05/20244:30PMGlobeNewswire Inc.Integra LifeSciences to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:IARTIntegra LifeSciences Holdings Corporation
12/20/20234:57PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IARTIntegra LifeSciences Holdings Corporation
12/13/20234:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IARTIntegra LifeSciences Holdings Corporation
12/13/20234:43PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IARTIntegra LifeSciences Holdings Corporation
12/13/20234:31PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IARTIntegra LifeSciences Holdings Corporation
12/13/20237:03AMDow Jones NewsIntegra LifeSciences to Buy Acclarent From Johnson & JohnsonNASDAQ:IARTIntegra LifeSciences Holdings Corporation
12/13/20236:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IARTIntegra LifeSciences Holdings Corporation
12/13/20236:15AMGlobeNewswire Inc.Integra LifeSciences Announces Definitive Agreement to Acquire Acclarent®NASDAQ:IARTIntegra LifeSciences Holdings Corporation
12/12/202312:00PMGlobeNewswire Inc.Integra LifeSciences Appoints Jeff Graves, Ph.D., to Board of DirectorsNASDAQ:IARTIntegra LifeSciences Holdings Corporation
 Showing the most relevant articles for your search:NASDAQ:IART